Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer

Name: Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer
Published: 2012
License: Public Domain

Karyopharm Therapeutics Inc · 2012

ClinicalTrials.gov · Datasets · License: Public Domain · 2012

Open Source ↗

hematological-malignancies multiple-myeloma

hematological malignancies, selinexor, kpt-330, multiple myeloma, non-hodgkin lymphoma, chronic lymphocytic leukemia, waldenström's macroglobulinemia, peripheral t-cell lymphoma, cutaneous t-cell lymphoma, chronic myelocytic leukemia, acute lymphoblastic leukemia, interventional

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer

Related documents